Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

Summary

To date, few studies have assessed the efficacy and safety of Cannabinoids, compounds derived from the Cannabis plant, in patients with Crohn's disease. Our study seeks to pilot a randomized, placebo-controlled trial assessing the efficacy and safety of oral cannabinoids as an adjunct therapy in patients with Crohn's disease.

Timeline

Start

2018-07

Primary completion

2019-07

Completion

2019-07

Drugs

Indications